 |
 |

Nasopharyngectomy After Failure of 2 Courses of Radiation Therapy
Hani Z. Ibrahim, MD;
Melinda S. Moir, MD;
Willard W. Fee, MD
Arch Otolaryngol Head Neck Surg. 2002;128:1196-1197.
Background Recurrence of nasopharyngeal carcinoma after initial therapy has been
reported to range between 18% and 54%. As an alternative to surgical salvage,
patients with recurrent nasopharyngeal carcinoma are offered a second course
of radiation therapy. If this second course fails, patients may be candidates
for surgical resection.
Objective To identify the effectiveness and morbidity of surgical resection of
recurrent nasopharyngeal carcinoma in patients who have received 2 cycles
of external beam radiation.
Design and Setting Retrospective survey of 6 patients in a university-based practice who
underwent resection of recurrent nasopharyngeal carcinoma after 2 courses
of radiation therapy.
Patients Our study group comprised 4 women and 2 men aged between 35 and 67 years.
All patients underwent 2 courses of radiation with a mean total dose of 11 500
rad (115 Gy) (range, 9500-13 200 rad [95-132 Gy]) delivered to the nasopharynx
prior to resection. The mean duration between the second course of radiation
and resection is 21 months (range, 8-52 months). The mean follow-up period
is 7.2 years (range, 4.2-11.5 years).
Intervention Nasopharyngectomy after failure of 2 courses of radiation therapy.
Main Outcome Measures Postoperative clinical outcome and morbidity.
Results Five years after resection, 1 patient died of disease. The remaining
5 patients (83%) are alive with no evidence of disease. Osteomyelitis is the
most common complication, affecting 5 patients. Three of the 5 patients with
osteomyelitis required operative debridement of the nasopharynx and split-thickness
skin grafting. Other complications include oronasal fistula (2 patients),
chronic otitis media (2 patients), and nasopharyngeal stenosis (1 patient).
Conclusion Although poor wound healing is evident, the overall 5-year survival
of 83% is encouraging.
From the Department of Otolaryngology & Bronchoesophagology, Rush-Presbyterian-Saint
Luke's Medical Center, Chicago, Ill (Dr Ibrahim); and the Division of OtolaryngologyHead
& Neck Surgery, Stanford University Medical Center, Stanford, Calif (Drs
Moir and Fee).
|